• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.25% Nasdaq Up0.65%

    More On SAZ.DE

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    • Analyst Opinion
    • Analyst Estimates

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials


    Stada-Arzneimittel AG (SAZ.DE)

    -XETRA
    49.20 Up 1.62(3.40%) May 27, 11:35AM EDT
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingMar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015
    Total Revenue 497,000   582,000   508,000   540,000  
    Cost of Revenue256,000  298,000  262,000  279,000  
    Gross Profit 242,000   283,000   245,000   261,000  
    Operating Expenses
    Research Development -   -   -   -  
    Selling General and Administrative -   -   -   -  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses441,000  481,000  435,000  478,000  
    Operating Income or Loss 56,000   100,000   73,000   62,000  
    Income from Continuing Operations
    Total Other Income/Expenses Net -   -   -   -  
    Earnings Before Interest And Taxes56,000  100,000  73,000  62,000  
    Interest Expense(13,000)(12,000)(16,000)(19,000)
    Income Before Tax -   -   -   -  
    Income Tax Expense12,000  6,000  14,000  9,000  
    Minority Interest(2,000)(2,000)(2,000)(2,000)
    Net Income From Continuing Ops32,000  22,000  38,000  34,000  
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income 30,000   20,000   36,000   32,000  
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares -   -   -   -  

    Currency in EUR.